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IMPORTANCE Delay discounting is a behavioral economic index of impulsive preferences for
smaller-immediate or larger-delayed rewards that is argued to be a transdiagnostic process
across health conditions. Studies suggest some psychiatric disorders are associated with
differences in discounting compared with controls, but null findings have also been reported.
OBJECTIVE To conduct a meta-analysis of the published literature on delay discounting in
people with psychiatric disorders.
DATA SOURCES PubMed, MEDLINE, PsycInfo, Embase, and Web of Science databases were
searched through December 10, 2018. The psychiatric keywords used were based on DSM-IV
or DSM-5 diagnostic categories. Collected data were analyzed from December 10, 2018,
through June 1, 2019.
STUDY SELECTION Following a preregistered Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) protocol, 2 independent raters reviewed titles,
abstracts, and full-text articles. English-language articles comparing monetary delay
discounting between participants with psychiatric disorders and controls were included.
DATA EXTRACTION AND SYNTHESIS Hedges g effect sizes were computed and random-effects
models were used for all analyses. Heterogeneity statistics, one-study-removed analyses, and
publication bias indices were also examined.
MAIN OUTCOMES AND MEASURES Categorical comparisons of delay discounting between
a psychiatric group and a control group.
RESULTS The sample included 57 effect sizes from 43 studies across 8 diagnostic categories.
Significantly steeper discounting for individuals with a psychiatric disorder compared with
controls was observed for major depressive disorder (Hedges g = 0.37; P = .002; k = 7),
schizophrenia (Hedges g = 0.46; P = .004; k = 12), borderline personality disorder (Hedges
g = 0.60; P < .001; k = 8), bipolar disorder (Hedges g = 0.68; P < .001; k = 4), bulimia
nervosa (Hedges g = 0.41; P = .001; k = 4), and binge-eating disorder (Hedges g = 0.34;
P = .001; k = 7). In contrast, anorexia nervosa exhibited statistically significantly shallower
discounting (Hedges g = –0.30; P < .001; k = 10). Modest evidence of publication bias was
indicated by a statistically significant Egger test for schizophrenia and at the aggregate level
across studies.
CONCLUSIONS AND RELEVANCE Results of this study appear to provide empirical support for
delay discounting as a transdiagnostic process across most of the psychiatric disorders
examined; the literature search also revealed limited studies in some disorders, notably
posttraumatic stress disorder, which is a priority area for research.
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E xamination of underlying neurocognitive processes thattranscend multiple diagnostic categories is a long-standing priority in psychiatry. Consistent with this fo-
cus is the Research Domain Criteria (RDoC) framework from the
US National Institute of Mental Health,1,2 which seeks to char-
acterize the fundamental domains of cognitive, perceptual, and
social processing with the aim of identifying novel targets for
the treatment of mental health disorders. Within the RDoC
framework, the behavioral economic index of delay discount-
ing, which captures the extent to which rewards lose value over
a temporal delay, has emerged as a promising paradigm.3 De-
lay discounting is commonly assessed through intertemporal
choice tasks involving choices between immediate and de-
layed rewards (eg, money) to estimate a person’s discounting
rate (k) or other quantitative indices (eg, area under the curve,
impulsive choice ratio). Steeper delay discounting and, subse-
quently, smaller area under the discounting curve is fre-
quently interpreted as reflecting an impulsive preference for
immediate rewards over delayed gratification.4,5
A growing body of research has solidified the relevance of
delay discounting in the context of psychiatric disorders. This
relevance has led to the proposal that excessive discounting
of delayed rewards is a transdiagnostic process (ie, a behavior
exhibited across multiple disorders that may provide novel
insights into the common underlying features of those
disorders).6,7 Furthermore, Levin et al8 proposed that in-
vestigating delay discounting across disorders may help
inform transdiagnostic treatments by identifying target
behavioral processes and providing markers of change in
existing treatments.
Previous narrative reviews by Bickel et al6 and Lempert
et al3 have summarized evidence of steep discounting associ-
ated with numerous health conditions, with addictive disor-
ders, attention-deficit/hyperactivity disorder (ADHD), and
obesity being among the most extensively studied domains to
date. Several meta-analyses have reported consistent evi-
dence of impulsive discounting associated with each of these
disorders.9-12 In addition, Bickel et al6 and Lempert et al3 also
summarized evidence of steep delay discounting in several
other psychiatric disorders, including schizophrenia,13,14 bi-
polar disorder,13,15 major depressive disorder,16,17 and border-
line personality disorder.18,19 In contrast, disorders such as an-
orexia nervosa20,21 and obsessive-compulsive personality
disorder22 are associated with shallower discounting com-
pared with healthy controls. Therefore, the existing litera-
ture suggests that delay discounting lies on a continuum (Fig-
ure 2 in Lempert et al3). Indexing the location of different
disorders along this continuum may elucidate the degree to
which delay discounting should be considered as a viable and
necessary treatment target in the pursuit of ameliorating trans-
diagnostic symptoms.
Narrative reviews are valuable for summarizing findings
and stimulating new research on the role of delay discount-
ing in the broad field of psychiatry, but to our knowledge, a
quantitative synthesis of the research on psychiatric disor-
ders (apart from addictive disorders and ADHD) has yet to be
published. A quantitative meta-analysis is necessary for sev-
eral reasons. First, although a preponderance of individual
studies have reported statistically significant differences
between individuals with psychiatric disorders and healthy
controls, a notable number of studies have not found these
differences,23-26 suggesting a need to clarify the nature and
relative weight of the collective evidence to date. Second, a
meta-analytic approach involves a systematic literature
search that may identify additional studies or disorder cat-
egories otherwise excluded from narrative reviews. Third, a
meta-analysis provides important quantitative data, includ-
ing estimates of aggregate effect sizes across studies, in-
dices of between-study heterogeneity, and evaluation of
publication bias.
The goal of the current study was to conduct a meta-
analysis of studies comparing delay discounting between in-
dividuals with psychiatric disorders and nonclinical compari-
son groups. Based on the hypothesis that delay discounting
is a transdiagnostic process, we hypothesized the existence of
robust differences across studies between individuals with
psychiatric disorders and healthy controls.
Methods
Search Strategy
The meta-analysis protocol was preregistered on PROSPERO
(The International Prospective Register of Systematic Re-
views) (CRD42018105385). Candidate studies were identi-
fied through searches of PubMed, MEDLINE, PsycInfo, Embase,
and Web of Science through December 10, 2018. Discounting
keywords were combined using Boolean logic with psychiat-
ric keywords based on DSM-IV and DSM-5 diagnostic catego-
ries (the complete list of search terms is presented in eTable 1
in the Supplement, and a licensed clinical psychologist [R.E.M.]
reviewed the psychiatric keyword list). Addiction or ADHD-
associated keywords were not included to avoid redundancy
with published meta-analyses.9,11,12 Keywords associated with
other neurodevelopmental disorders (eg, autism spectrum
disorders) were excluded. In addition, the reference lists of re-
cent reviews were manually searched for additional studies.
Key Points
Question Is delay discounting a transdiagnostic process in
psychiatric disorders?
Findings In this meta-analysis of 57 effect sizes from 43 studies
across 8 diagnostic categories, robust differences in delay
discounting were observed between people with psychiatric
disorders and controls. Most individuals with disorders (including
depression, bipolar disorder, schizophrenia, borderline personality
disorder, bulimia nervosa, and binge-eating disorder) exhibited
steeper discounting compared with controls, whereas those with
anorexia nervosa exhibited shallower discounting compared with
controls.
Meaning Evidence from this study suggests that delay
discounting decision-making is a robust transdiagnostic process
across a range of psychiatric disorders and may be a viable target
for treatment interventions.
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Inclusion Criteria and Study Selection
For inclusion, studies had to meet the following criteria: (1) pub-
lished in a peer-reviewed journal, (2) available in the English
language, (3) involved human participants, (4) included a mon-
etary delay discounting measure, (5) performed a categorical
comparison between individuals with a psychiatric diagnosis
based on a validated diagnostic instrument (eg, SCID [Struc-
tured Clinical Interview for DSM]27,28) and controls, and (6) as-
sessed monetary delay discounting under neutral conditions
(eg, no experimental stress or affect manipulations). Studies
with multiple discounting assessments (eg, accelerated vs de-
layed versions21,22,29) were included as these were not con-
sidered to be manipulations designed to alter mood or emo-
tional state; however, these studies were collapsed into a single
effect size in a follow-up analysis. Although a limited number
of studies have assessed nonmonetary commodities (eg, food,
effort), we focused on money as the most commonly and con-
sistently assessed reward. Studies focused on comorbid sub-
stance use disorders and psychiatric disorders30,31 were not
included because disentangling the associations between sub-
stance use disorder and psychiatric illness was not possible.
A minimum of 4 effect sizes was required for a diagnostic cat-
egory to be included in the meta-analysis.
Study selection was completed in Covidence (Veritas
Health Innovation Inc). The selection procedure is depicted
in Figure 1 and followed Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analysis (PRISMA) standards.32 Two
of us (M.A. and E.M.) independently screened titles and
abstracts for clearly eligible or ineligible studies. Studies with
conflicting ratings were discussed, and a consensus decision
was reached between M.A. and E.M., with additional
clarification from R.M as needed. The same process was
repeated for full-text articles.
Sample Characteristics
Characteristics of the included studies13-26,29,33-60are pre-
sented in Table 1; a list of excluded full-text articles and
reasons for exclusion is provided in eTable 4 in the Supple-
ment. Disorder categories reflected the primary diagnosis for
the clinical group; inclusion or exclusion of other comorbidi-
ties varied across studies but was not considered in the pre-
sent analyses. Notable details of the participant characteris-
tics were that only 1 study on bipolar disorder15 specified
whether participants were in a manic or depressive state at test-
ing, 1 study on binge-eating disorder33 included controls who
were overweight or obese, and Wierenga et al34 included in-
dividuals with remitted anorexia nervosa. Although studies
that explicitly focused on concurrent addictive and psychiat-
ric disorders were excluded, a number of studies did include
participants with varying levels of substance use. However, lev-
els of substance use were not consistently reported or con-
trolled for across studies, so we were unable to examine this
factor in the present analyses. Readers are encouraged to con-
sult the original articles for information on psychiatric comor-
bidities and substance use.
Studies also varied in the methods used to measure and
quantify delay discounting (Table 1). Although all studies ex-
amined money, the reward magnitudes varied from small (ie,
$0.15 to approximately $30) to large (ie, $500-$1000). Most
studies used either a delay discounting task (ie, adjusting
amount or delay) or the monetary choice questionnaire,61 with
1 study using an experiential discounting task.15 Hyperbolic dis-
counting rate and area under the curve were the most com-
mon indices of discounting, with impulsive choice ratio and
other indices also used.
Meta-analytic Approach
Comprehensive Meta-Analysis, version 3.0 (Biostat), was
used for all analyses. The primary effect size was Hedges g,
which is ideal when aggregating studies with small sample
sizes owing to the statistic’s correction for small study
bias.62 Two of us (M.A. and E.M.) independently extracted
and checked quantitative values (raw data values are pro-
vided in eTable 2 in the Supplement). When the required
data were not reported in the published article, we con-
tacted the corresponding authors (9 authors provided data,
and data remained unavailable for 1 study). Effect sizes
from studies using area under the curve or indifference
points were reversed prior to analysis.
Separate meta-analyses were conducted for each diagno-
sis category using a random-effects model. Several indices of
effect size heterogeneity were calculated. Cochran Q test re-
flects the sum of squared differences between individual
weighted study effects and the overall mean. I2 statistic cap-
tures the proportion of variation within study effect sizes ex-
plained by heterogeneity. The tau (τ) reflects the SD of the mean
effect. Borenstein et al62 emphasized that Q is less reliable with
small sample sizes, whereas I2 and τ are not affected by sample
size; thus, all 3 statistics were reported to be comprehensive.
A one-study removed (OSR) analysis quantified the associa-
tion of individual studies with the aggregate results.63 Fur-
thermore, to evaluate the overrepresentation by studies
adding multiple effect sizes, we repeated the primary analy-
sis after consolidation into a single effect size per study.
Publication bias was evaluated using multiple indices, in-
cluding examination of the funnel plots using the 2-tailed
Figure 1. Diagram of Study Selection and Inclusion
2941 Records identified 
through database search
9 Records identified 
through reference lists
1576 Records screened
141 Full-text articles 
screened for eligibility
43 Studies included in 
meta-analysis
1374 Duplicates excluded
1435 Irrelevant records excluded















Insufficient No. of studies
in category
Data not available
Research Original Investigation Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders
1178 JAMA Psychiatry November 2019 Volume 76, Number 11 (Reprinted) jamapsychiatry.com
© 2019 American Medical Association. All rights reserved.
Downloaded From: https://jamanetwork.com/ by a University of Kansas Libraries User  on 02/17/2021
Table 1. Characteristics of Included Studies












MDD (32); HC (61) DSM-IV DDT $10 k
Cáceda et al,17
2014
MDD (20); HC (20) DSM-IV MCQ $55 (mean) k
Dombrovski
et al,40 2011
MDD (42); HC (31) DSM-IV MCQ $55 (mean) k
Engelmann et al,38
2013
MDD (11); HC (15) DSM-IV DDT $10 000 β
Imhoff et al,16
2014
MDD (20); HC (20) BDI DDQ $10 AUC
Pulcu et al,41 2014 MDD (24); HC (29) DSM-IV MCQ $75-$85 k
Weidberg et al,23
2015
MDD (30); HC (65) BDI DDT €1000 k
Schizophrenia
Ahn et al,13 2011 SZ/SZA (21); HC (30) DSM-IV DDT $800 k
Avsar et al,36 2013 SZ/SZA (14); HC (14) DSM-IV DDT $28-86 k
Brown et al,39
2018
SZ/SZA (31); HC (61) DSM-IV DDT $10 k
Heerey et al,14
2007
SZ/SZA (42); HC (29) DSM-IV MCQ $55 (mean) k
Heerey et al,37
2011
SZ (37); HC (24) DSM-IV DDT $75-$85 k
Horan et al,42
2017
SZ (131); HC (70) DSM-IV DDT $1000 AUC
MacKillop and
Tidey,43 2011
SZ/SZA (23); HC (24) DSM-IV MCQ $25-$85 k
Wang et al,44 2018 SZ (25); HC (30) DSM-IV DDT $45 ICR
Wing et al,24 2012 SZ/SZA (34); HC (37) DSM-IV MCQ $55 (mean) k




BPD (19); HC (21) DSM-IV DDT £100 k
Berenson et al,46
2016
BPD (35); HC (45) DSM-IV DDT $55 (mean) k
Coffey et al,47
2011
BPD (19); HC (28) DSM-IV DDT $1000 k
Dougherty et al,48
1999
BPD (13); HC (17) DSM-III DDT $.15 ICR
Krause-Utz et al,49
2016
BPD (25); HC (24) DSM-IV DDT €100 k
Lawrence et al,19
2010
BPD (30); HC (28) DSM-IV DDT $1000 k
Maraz et al,25
2016
BPD (36); HC (111) ICD-10 DDT 50 000 HUF k
Bipolar Disorder
Ahn et al,13 2011 BP (22); HC (30); manic-depressive
state not specified
DSM-IV DDT $800 k
Brown et al,39
2018
BP (16); HC (61); manic-depressive
state not specified
DSM-IV DDT $10 k
Strakowski et al,15
2010
BP (108); HC (48); acute
manic/mixed-episode state
DSM-IV eDDT $.15 ICR
Urošević et al,50
2016
BP (32); HC (32); manic-depressive
state not specified




OCD (20); HC (20) ICD-10 DDT £100 k
Pinto et al,22 2014 OCD (25); HC (25) DSM-IV DDT $80-$100 AUC
Sohn et al,35 2014 OCD (80); HC (76) DSM-IV DDT $100 k
(continued)
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Begg-Mazumdar test64 and the 1-tailed Egger test.65 Owing to
low statistical power for the funnel plot indices with small
sample sizes,66 statistical significance of the funnel plot indi-
ces was considered only in categories with 10 or more effect
sizes. Adjusted estimates of effect size were also generated ac-
cording to imputed unpublished studies using the Duval and
Tweedie trim-and-fill approach.67 A 2-tailed significance value
of P < .05 was used for all aggregate tests.
Results
The results of the meta-analyses by disorder category are pre-
sented in Table 2, and forest plots by category are provided in
Figure 2. Complete statistical results for individual studies are
provided in eTable 3 in the Supplement. A total of 43 studies
met the inclusion criteria, yielding 57 effect sizes. Eight dis-
order categories had sufficient effect sizes (ie, k≥4) to be in-
cluded (Table 2). All disorder categories, except anorexia ner-
vosa, exhibited statistically significantly steeper (more
impulsive) delay discounting compared with controls: major
depressive disorder (Hedges g = 0.37; P = .002; k = 7), schizo-
phrenia (Hedges g = 0.46; P = .004; k = 12), borderline per-
sonality disorder (Hedges g = 0.60; P < .001; k = 8), bipolar dis-
order (Hedges g = 0.68; P < .001; k = 4), bulimia nervosa
(Hedges g = 0.41; P = .001; k = 4), binge-eating disorder (Hedges
g = 0.34; P = .001; k = 7), and obsessive-compulsive disorder
(Hedges g = 0.30; P = .002; k = 5). Studies of anorexia ner-
vosa revealed the opposite pattern, with the clinical group
exhibiting shallower (less impulsive) discounting compared
with controls (Hedges g = –0.30; P < .001; k = 10). The largest
aggregate effect sizes were observed for bipolar disorder and
borderline personality disorder, with each of these reflecting
medium-sized effects based on conventional interpretation.
Small to medium effect sizes (Hedges g = 0.30-0.46) were ob-
served for the other categories.
Statistically significant evidence of heterogeneity based on
the Cochran Q statistic was found for 3 of the disorder catego-
Table 1. Characteristics of Included Studies (continued)















BN (27); HC (28); all female DSM-5 DDT £100 AUC
Kekic et al,29 2016 BN (39); HC (53) DSM-5 DDT £100-£130 DF
Neveu et al,54
2014




BED (11); HC (28); all female DSM-5 DDT £100 AUC
Davis et al,55 2010 BED (65); HC (71) DSM-IV DDT $100 IDP
Manasse et al,33
2015
BED (31); obese/overweight controls
(43); all female
EDE DDT $1000 AUC
Manwaring et al,56
2011
BED (27); HC (30); all female DSM-IV DDT $100 AUC
Mole et al,57 2015 BED (30); HC (30) DSM-IV MCQ $55 (mean) k
Steward et al,58
2017
BED (24); HC (80); all female DSM-IV MCQ $55 (mean) k




AN (28); HC (28); all female DSM-5 DDT £100 AUC
Decker et al,20
2015
AN (54); HC (39) DSM-5 DDT $5-$40 k
King et al,60 2016 AN (31); HC (31); all female DSM-IV DDT €30 k
Neveu et al,54
2014
AN-R (16); HC (18); all female DSM-IV DDT €10 k
Ritschel et al,26
2015
AN (34); HC (53); all female DSM-IV DDT €20-€789 k
Steinglass et al,21
2012
AN (36); HC (28) DSM-IV DDT $80-100 DF
Steinglass et al,52
2017
AN (27); HC (75) DSM-IV DDT $47-$78 k
Steward et al,58
2017
AN-R (37); HC (80); all female DSM-IV MCQ $55 (mean) k
Wierenga et al,34
2015
Remitted AN (23); HC (17) DSM-IV DDT $47-$78 ICR
Abbreviations: AN, anorexia;
AN-R, anorexia-restrictive subtype;
AUC, area under the curve; BDI, Beck
Depression Inventory;
BED, binge-eating disorder;
BES, Binge Eating Scale; BN, bulimia
nervosa; BP, bipolar disorder;
BPD, borderline personality disorder;
DD, delay discounting; DDT, delay
discounting task; DF, discount factor;
eDDT, experiential-type delay
discounting task; EDE, Eating
Disorder Examination; HC, healthy
controls; ICR, impulsive choice ratio;
IDP, indifference point; k, hyperbolic
discounting rate; MCQ, monetary




€, Euro; HUF, Hungarian Forint;
¥, Japanese yen; £, UK pound;
$, US dollar.
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ries (major depressive disorder, schizophrenia, and border-
line personality disorder). However, the I2 and τ statistics sug-
gested that heterogeneity was also present for bipolar disorder
and binge-eating disorder. A nonsignificant Cochran Q may re-
sult from low power from the small number of studies in these
disorder categories.
The OSR analysis showed that the results for all disorder
categories except obsessive-compulsive disorder were gener-
ally stable (eTable 3 in the Supplement). For obsessive-
compulsive disorder, omitting the study by Sohn et al35 re-
sulted in a nonsignificant aggregate effect size (Hedges
g = 0.20; P = .11). Although the remaining OSR analyses yielded
statistically significant aggregate effect sizes, a small number
of studies with larger effect sizes tended to have a dispropor-
tionate association with the aggregate effect sizes for major
depressive disorder23 (OSR Hedges g = 0.45; P < .001) and
schizophrenia36 (OSR Hedges g = 0.34; P = .01).
For the 5 disorder categories that included multiple ef-
fect sizes from individual studies, we recalculated the aggre-
gate effect sizes after consolidating to a single effect size per
study. This recalculation yielded generally similar estimates
of aggregate effect size for schizophrenia (Hedges g = 0.52), bor-
derline personality disorder (Hedges g = 0.64), obsessive-
compulsive disorder (Hedges g = 0.30), anorexia nervosa
(Hedges g = –0.30), and bulimia nervosa (Hedges g = 42).
An exploratory analysis examined the association be-
tween reward magnitude and the effect sizes obtained, irre-
spective of diagnosis. Magnitudes were coded into 3 catego-
ries: small (<$100; k = 33), medium ($100-$499; k = 14) or large
(≥$500; k = 10). Modest differences in effect sizes were ob-
served for small (Hedges g = 0.41; 95% CI, 0.29-0.52; P < .001),
medium (Hedges g = 0.38; 95% CI, 0.23-0.53; P < .001), and
large (Hedges g = 0.53; 95% CI, 0.21-0.85; P = .001) rewards,
but the test of heterogeneity was nonsignificant (Cochran
Q = 0.71; P = .70).
Publication Bias
Publication bias indices are reported in Table 3. Two disorder
categories (schizophrenia and anorexia nervosa) had more than
the recommended minimum of 10 studies for the Begg-
Mazumdar test or Egger test. The Egger intercept was statis-
tically significant for schizophrenia. Major depressive disor-
der and bipolar disorder were determined to have missing effect
sizes, using the trim-and-fill method (see Table 3 for imputed
effect sizes). To explore publication bias more broadly, we ag-
gregated the 57 effect sizes into a single analysis. The Kendal
tau was nonsignificant (P = .24), but the Egger test intercept
was significant (Egger intercept = 2.2; P = .001). The trim-and-
fill method indicated no missing studies. In sum, minimal to
modest evidence for publication bias was found, but these in-
dices should be considered with caution given the relatively
small number of studies for most disorder categories.66
Discussion
This meta-analysis evaluated the evidence supporting delay
discounting as a transdiagnostic process in psychiatric disor-
ders. Consistent with our hypotheses, statistically significant
aggregate effect sizes were observed for all disorder catego-
ries included in the meta-analysis, although OSR sensitivity
analyses indicated that the aggregate effect size was not reli-
able for obsessive-compulsive disorder. Although the rela-
tively small number of studies in many of the disorder catego-
ries precluded thorough consideration of publication bias, the
tests examined suggested modest evidence of small study bias.
The primary findings are consistent with the view that de-
lay discounting exists on a continuum.3 Most of the disorder
categories examined were characterized by steep discount-
ing in those who had the disorder compared with controls,
whereas individuals with anorexia nervosa exhibited the
opposite pattern. Taken together, the results support the trans-
diagnostic nature of delay discounting, although the overall
magnitude of differences is not uniform across psychiatric dis-
orders. Bipolar disorder and borderline personality disorder had
the largest effect sizes, with differences between groups being
in the medium magnitude range. The effect sizes for these dis-
orders are comparable to the effect sizes reported in addic-























7 420 0.37 .002 0.14 to 0.61 0.29 to 0.44 8.31 .22 27.82 0.17




8 451 0.60 <.001 0.32 to 0.87 0.51 to 0.67 15.74 .028 55.53 0.29




5 371 0.30 .002 0.11 to 0.49 0.20 to 0.34 3.77 .44 0.00 0.00
Bulimia nervosa 4 183 0.41 .001 0.17 to 0.65 0.31 to 0.47 1.85 .60 0.00 0.00
Binge-eating
disorder
7 1483 0.34 .001 0.13 to 0.56 0.29 to 0.45 10.63 .10 43.53 0.18
Anorexia nervosa 10 655 −0.30 <.001 −0.46 to −0.14 −0.27 to −0.35 10.31 .33 12.73 0.09
Abbreviations: I2, proportion of variability from heterogeneity; OSR, one-study removed, or range of effect sizes obtained from OSR jackknife analysis.
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tion studies (d = 0.67 in MacKillop et al9). The other disorder
categories had somewhat smaller effect sizes that were gen-
erally comparable to that for ADHD in meta-analytic findings
(d = 0.43 in Jackson and MacKillop12). From the standpoint of
the RDoC framework, these findings appear to highlight the
need to continue looking into different ways to classify pre-
senting difficulties using a continuum rather than general cat-
egories based on DSM diagnoses.
These results raise intriguing questions about the shared
underlying mechanisms that might explain the consistent as-
sociation among disorder categories. One neurocognitive
mechanism that is commonly discussed in the context of ad-
diction is impaired self-control, which is associated with dys-
function in competing neurobehavioral decision systems68,69
The competing neurobehavioral decision systems model pos-
its that delay discounting may be associated with 2 compet-
ing neural systems: a frontal cortical system that exerts ex-
ecutive control and a limbic-subcortical system that drives
immediate reward seeking. According to this model, addic-
tion is characterized by excessive activation of the limbic cir-
cuit and dysfunction in the frontal circuit. Disruption in these
neural systems has theoretical relevance to many of the other
psychiatric disorders we examined.70-76 For example, the vari-
ous eating disorder diagnoses illustrate both ends of the com-
peting neurobehavioral decision systems balance. Excessive
self-control over food intake in anorexia has been associated
Figure 2. Forest Plots of Primary Meta-analytic Results by Disorder Category
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Hedges g (95% CI)
–2 0 2–1 1






DDSource Hedges g (95% CI)
Aggregate effect size
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Borderline personality disorder
Aggregate effect size
Urošević et al,50 2016
Brown et al,39 2018
Strakowski et al,15 2010
Ahn et al,13 2011
0.68 (0.38 to 0.99)
0.37 (–0.11 to 0.86)
0.53 (0.19 to 0.87)
0.85 (0.38 to 1.32)
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Aggregate effect size
Neveu et al,54 2014
Kekic et al,29 2016 (accelerate)
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Bartholdy et al,53 2017
0.41 (0.17 to 0.65)
0.35 (–0.30 to 0.99)
0.63 (0.21 to 1.05)
0.37 (–0.04 to 0.79)
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Bulimia nervosa
Mole et al,57 2015
Manwaring et al,56 2011
Davis et al,55 2010
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Bartholdy et al,53 2017
0.74 (0.22 to 1.25)
Steward et al,58 2017 0.50 (0.04 to 0.95)
Yan et al,59 2018 0.06 (–0.17 to 0.28)
Aggregate effect size 0.34 (0.13 to 0.56)
0.20 (–0.31 to 0.72)
0.58 (0.11 to 1.04)
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Binge–eating disorder
Ritschel et al,26 2015
Neveu et al,54 2014
Decker et al,20 2015
King et al,60 2016
Bartholdy et al,53 2017
0.00 (–0.43 to 0.42)
Steinglass et al,21 2012 (accelerate) –0.47 (–0.97 to 0.02)
Steinglass et al,21 2012 (delay) –0.30 (–0.79 to 0.19)
Steinglass et al,52 2017 –0.40 (–0.84 to 0.04)
Steward et al,58 2017 –0.42 (–0.81 to –0.03)
Wierenga et al,34 2015 –0.16 (–0.78 to 0.46)
Aggregate effect size –0.30 (–0.46 to –0.14)
0.35 (–0.31 to 1.02)
–0.10 (–0.59 to 0.39)
–0.48 (–0.89 to –0.06)
–0.70 (–1.24 to –0.17)
Anorexia nervosa
Act indicates actual rewards; DD, delay discounting; and Hyp, hypothetical rewards. Square data points reflect effect size (Hedges g) for each study, with whiskers
reflecting 95% CIs. Diamonds reflect aggregate effect sizes (Hedges g) for each category, with width of diamond indicating 95% CI.
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with exaggerated activity in dorsal cognitive circuits,77 whereas
reduced self-control in bulimia nervosa and binge-eating dis-
order is partially associated with disruption in the similar fron-
tal circuits.77,78
Other psychological mechanisms may explain the
observed results. First, future-oriented cognitive processes,
such as episodic future thinking,79 are important for pro-
spectively considering larger delayed rewards in the context
of delay discounting. Numerous psychiatric disorders are
characterized by deficits in episodic future thinking, includ-
ing major depressive disorder, bipolar disorder, schizophre-
nia, borderline personality disorder, eating disorders, and
addictive disorders.37,80-83 Moreover, shifting a person’s
focus toward the future through experimental episodic
future thinking training has been shown to decrease impul-
sive delay discounting in healthy samples or individuals
with addiction,84-87 but this shift had not been examined in
the other psychiatric disorders included in this study. A sec-
ond psychological mechanism relates to intolerance of
uncertainty, or the tendency to react negatively to uncertain
situations.88 Because delayed rewards may be interpreted as
uncertain, increased preferences for immediate rewards on
discounting tasks could also be explained by heightened
intolerance of uncertainty. Consistent with this hypothesis,
a positive correlation between steeper discounting and
higher scores on an intolerance-of-uncertainty scale was
found in a study of healthy participants.89 Although numer-
ous psychiatric disorders are characterized by heightened
intolerance of uncertainty,88,90,91 we are not aware of any
studies in psychiatric samples that have examined the inter-
section between this construct and discounting.
Further clarifying the clinical significance of differences
in delay discounting appears to be a priority for psychiatric
research. In particular, examining whether delay discount-
ing is associated with specific symptoms or symptom clus-
ters may provide greater clinical precision. The studies
included in this meta-analysis focused on broad diagnostic
categories and not specific subtypes or symptoms within
disorders. This focus is an important consideration given
that a limited number of previous studies have reported
symptom-level associations. For example, the presence of
anhedonia (a symptom of major depressive disorder) is
associated with decreased discounting,92 and discounting is
associated with specific symptoms of schizophrenia (eg,
apathy93). Unfortunately, insufficient research is currently
available on symptom-level associations to permit meta-
analyses.
Another priority is determining whether discounting
prospectively estimates treatment outcomes, in which the
motivation and willingness to take active steps toward
therapeutic goals may be more challenging for individuals
who struggle to reliably weigh the advantages of short-term
against long-term rewards. This research would dovetail
with previous studies on discounting and substance use
treatment outcomes.31,94 Future research should also inves-
tigate whether discounting rates can be normalized via
treatment interventions.95 Various interventions such as
episodic future thinking training have been shown to reduce
impulsive discounting in individuals with addictive
disorders.85,86 Most of these techniques have focused on
reducing discounting, which makes them less applicable to
disorders with shallow discounting such as anorexia ner-
vosa. How discounting rates can be modified in both direc-
tions is an especially novel area of research.
Limitations
This study has a number of limitations. First, despite its
comprehensive literature search strategy, the study identi-
fied a relatively small number of studies for some disorder
categories. This small number may reduce confidence in the
accuracy of the aggregate effect sizes observed and con-
strained power for heterogeneity and publication bias tests.
Also notable was the insufficient number of articles on sev-
eral key disorders, including posttraumatic stress disorder,
generalized anxiety disorder, and other personality disor-
ders. Although a few studies examined delay discounting in
the context of trauma or posttraumatic stress disorder,38,96
the study designs and samples varied considerably. Charac-
terizing delay discounting in posttraumatic stress disorder
seems to be a priority.
Second, studies used a range of criteria and scales to
establish clinical diagnoses, which may have exaggerated
Table 3. Publication Bias Indices by Disorder Category
Disorder Kendall τ P Value Egger Intercept SE P Value Trim and Fill
Imputed
Hedges g
Major depressive disorder 0.71 .02a 4.93 0.96 .002a 2 0.26
Schizophrenia 0.24 .27 4.97 2.02 .02a 0 NA
Borderline personality disorder 0.00 >.99a 1.21 2.87 .34a 0 NA
Bipolar disorder 0.33 .497a 3.55 3.22 .19a 1 0.58
Obsessive-compulsive disorder −0.33 .46a −1.98 1.54 .14a 0 NA
Bulimia nervosa 0.00 >.99a −2.04 2.43 .25a 0 NA
Binge-eating disorder 0.14 .65a 1.98 1.26 .09a 0 NA
Anorexia nervosa −0.22 .42 2.64 2.15 .13 0 NA
Aggregate, All studies 0.11 .22 2.22 0.69 .001 0 NA
Abbreviation: NA, not applicable.
a Caution is warranted when interpreting P values for categories comprising fewer than 10 studies because of low statistical power.
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heterogeneity between studies. Third, although we excluded
studies that explicitly examined comorbid substance use and
psychiatric disorders, a few of the remaining studies in-
cluded participants who endorsed use of alcohol or tobacco,
whereas others did not report substance use data. Reporting
of this information was highly inconsistent across articles;
therefore, we were unable to identify the extent to which con-
current substance use may have been a factor in the effect sizes
obtained. Fourth, this analysis focused exclusively on mon-
etary discounting. Effect sizes were still in the small-to-
medium range for the eating disorder categories despite the
use of monetary rewards, but it is possible that other com-
modities (eg, food rewards or effort discounting97,98) may be
more sensitive in specific disorders.
Conclusions
To our knowledge, this meta-analysis is the first quantitative syn-
thesis of delay discounting findings in psychiatric disorders, ex-
cept ADHD and addictive disorders. This meta-analysis provides
relatively strong evidence that delay discounting is a transdiag-
nostic process in psychiatric disorders. The findings suggest that
discounting is not universally increased in all psychiatric disor-
ders but is more appropriately conceptualized as falling on a con-
tinuum. Together, the findings generally support the inclusion
of delay discounting in the RDoC framework and suggest that
discountingisarobustmarkerofpsychiatric illnessthatmayhave
clinical utility as a target for novel interventions.
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